Physician profile
Lora Johnson
NPI 1417449885
$353.89
in general payments reported to CMS, 2019-2025
14 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.43 · 2020: $16.80 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $51.82 | 2025 | |
| Corcept Therapeutics | $46.22 | 2025 | Korlym |
| Pfizer INC. | $40.02 | 2025 | |
| Lilly USA, LLC | $35.26 | 2020-2025 | Jardiance |
| Lundbeck LLC | $27.38 | 2025 | Rexulti |
| Novo Nordisk INC | $21.06 | 2025 | Ozempic, Rybelsus |
| Amgen INC. | $20.51 | 2025 | Evenity |
| Otsuka America Pharmaceutical, INC. | $19.68 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $18.99 | 2025 | Auvelity |
| Astellas Pharma US INC | $15.91 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $15.87 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $15.23 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.51 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.